Cymbalta is a brand name of duloxetineapproved by the FDA in the following formulation s:. A generic version of Cymbalta has been approved by the FDA.
The following products are equivalent to Cymbalta and have been approved by the FDA:. Fraudulent online pharmacies may attempt to sell an illegal generic version of Cymbalta, branded and generic drug.
These medications may be counterfeit and potentially branded and generic drug. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice branded and generic drug you are unsure about the online purchase of any medication.
Patents are granted by the U. A method of using N-methyl 1-naphthalenyloxy 2-thienyl propanamine to treat persistent pain. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
By clicking Subscribe, I agree to the Drugs. The easiest way to lookup drug information, identify pills, check interactions and set up your calcium and lipitor personal medication records. Available for Android and iOS devices. Subscribe to receive email notifications whenever new articles are published. This material is provided for educational purposes only and branded and generic drug not intended for medical advice, diagnosis or treatment.
To view content sources and attributions, please refer to our editorial policy. We comply with the HONcode standard for trustworthy health information - verify here. Generic Cymbalta Availability Cymbalta is a brand name of duloxetineapproved by the FDA in the following formulation s: August 3, Strength s: Print this page Add to My Med List. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation.
The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from branded and generic drug date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.
Drug Exclusivity Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from days to seven years depending upon the circumstance of the exclusivity grant.
By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. AB Products meeting necessary bioequivalence requirements. Multisource drug products listed under the same heading i. In certain instances, branded and generic drug, a number is added to the end of the AB code to make a three character branded and generic drug i.
Three-character codes are assigned only in situations when more than one reference listed drug of the same strength has been designated under the brights disease and diabetes heading.
Two or more reference listed drugs are generally selected only when there are at least two potential reference drug products which are not bioequivalent to each other. If a study is submitted that demonstrates bioequivalence to a specific listed drug product, the generic product will be given the same three-character code as the reference listed drug it was compared against. Cymbalta Rating User Reviews 6. Revcovi Nuzyra Nuzyra omadacycline is an aminomethylcycline tetracycline antibiotic for the treatment of Seysara Seysara sarecycline is an oral, narrow spectrum tetracycline-derived antibiotic for the treatment Xyosted Xyosted testosterone enanthate is a self-administered subcutaneous injection formulation of Subscribe to free Drugs.
FDA alerts for all medications. A drug patent is assigned by the U. Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent.
A Reference Listed Drug RLD is an approved drug product to which new generic versions are compared to show that they are bioequivalent. Products meeting necessary bioequivalence requirements.